ValiRx Share Chat (VAL)

Looking at the charts and mkt cap this is now a strong buy for a 3 month 50pct gain.

Im bullish at this depressed price.

Pumpdumpers? what are we doing here....

ridiculous

https://www.openbookanalytics.com/equity/VAL/risk

Notpotalot - for accuracy I think you mean 'Warrants at several price points (0.28p, 0.5p,1.3p) would give potential access to significant funds but would require a doubling, a near quadrupling and ten times multiple of the share price from today's levels and is therefore pretty unlikely as there is nothing commercial on even the far horizon to generate that level of rise.'

Pater and notpot are obv in constant contact with ME as its a huge embarrassment that we have crashed over 90pct under ME tenureship.

Will ME put shareholders first or the mate he works with. Thats the key for me .

I still think this is the buy zone.

Comrade Notpotalot, your devotion to the Ministry of Perpetual Re-rating has been duly recorded. 🫡

Today’s 10% drop to ~0.135p is, of course, not a fall but a strategic downward optimisation — down is up, especially if you keep saying it while averaging down.

The doctrine remains intact:

one RNS away — not wrong, merely eternally early. ⏳

Revenue? Happily absent. Cash runway? Creatively interpreted. Grants? Safest when still theoretical.

And dilution — ah yes — strength through expansion. The more shares exist, the more value there is to believe in.

So let us stand firm against the bedwetters:

those who read RNSs literally

those who remember placings

those who notice patterns

While the enlightened repeat the truths:

👉 progress ongoing

👉 discussions advancing

👉 transformation imminent

Just never inconveniently present.

War is Peace.

0.135p is the new 50p.

Doubleplusgood.

So Valirx is getting $4 and $8 million in grants? What a load of tripe.

The lab opened nearly 3 years ago - to generate revenue - revenues are non existent.

Awful cos have rallies ,dead cat bounces ,

I think we will bounce to 0.2 /0.25p but anything more than that will need ME to deliver which is something he hasn't done since becoming CEO.

Pater,no one reads your posts as youre paid to do VAL pr. its just a load of nonsense. Zero revs . Nothing will channge . So sell the next rally .

The Marker Makers must be worried ... halving the spread to 7.14% ... tells you everything.

So many on here averaging down - why average down when you could just sell?

So many hold and hopers on here. Very sad.

No, I'm not looking to "get in at a cheap price". The assets are not even worth £40k let alone £1.9 million.

Porky is right, this seems like a part-time job for those working here. Revenue zero or miniscule. No new projects and no money for them. What could they be doing all day? Waiting for the next discounted placing in 3-4 months. Shambles.

Nick is clever in that he awaits an optimistic RNS from ME before starting or piggy backing on the process.

He's always considerate enough to tell us when it is over.

If there is a pump and dump it'll need to be a good one - 50 percent rise just to make a tiny profit on the latest placing.

Speculation Slater is wearing the Emporas new clothes, how many times does he think he can get away with it🤔

Problem is we didnt raise wnough for investment.

Only enough to pay inflated wages . Apart from ME i dont believe there is anyone who works more than a couple of hours a day ..there just isn't anything to do.

Mark needs to wake up . Pay the right salaries and deliver some revenue instead of being totally dependent on the generosity of shareholders.

As ive said we need to raise £2m so we can actually buy into SPV’s. Cut salaries to the bone and make some part time . Stop WFH. Get Adam back on the BOD.

Make changes as I dont believe shareholders will fund any more of this non delivery again.

Sorry but this is possibly the worst of the AIM, I just find it incredible that a company can keep taking millions after millions after millions with shareholders continually being shafted and they just spunk the lot up the wall, ZERO accountability, ZERO delivery and keep getting rewarded with raise after raise - its totally obscene it really is. Only on AIM.

Its so predictable its painful, they will have spent the lot by November and will slip in another dilutive raise before the year is out and most likely another 125:1 consolidation before that to get the number of shares in issue back to a more manageable level again.

Its not even funny... its pathetic

'Expects.'

Not 'has.'

Ratcliffe: “RNSs are where the cold hard facts lie (or tell the truth)”

Val Annual Report RNS: “… The Board expects funding to cover AT LEAST 12 months from the date of approval” (i.e. June 2027 minimum)

Nice to have you on board, Rat.

You are delusional.

Any aim co that relies on grant funding in order to survive and pay excessive salaries to part time employees wont survive long. Its a shame as ME has invested a lot of money but i dont regard him as CEO material I'm afraid.

Cost base is crazy,hes ousted some good BOD members and made no progress with an expensive lab.

Its dire.Not happy as ME losing us all a lot of money.

Indeed, share4, what a team.

But they both appear to have lost their boiler room buddies, for now at least.

Paperpauper and notgotalot. ..what a team!

Pater

Can you explain to the BB why the majority of the recs for your recent posts have suddenly disappeared today?

Have admin intervened and put an end to your little games?

Where are all the recent director buys if everything is in place for some of our products to be commercialised asap. I have believed in the products all these years that's why I am thousands down. Let's hope there is a miracle around the corner with this company for the people that need to be treated for cancer. 👍🙏

Indeed financing is a concern for many companies that don't generate income, that's true. But let's stick to Val as this is the correct board - remind me how the Val 201 clinical trial is going will you? All gearing up for a NASDAQ listing is it....?

You got a quick 23 likes there..how odd ! Val staff obv love you !!

Its a huge paper loss and with NO chance of profits nothing will change .

Nick - “I feel sorry for ME as he's losing a fortune on his investment here which is never good to see”.

I must have missed that TR1 advising of ME’s sale. – what was the date? The last holding RNS I saw related to Mark was to confirm a further £50k buy only a few weeks ago, did you miss that one?

For info, you have to crystallise a loss or it remains just a paper loss. How many IMM, IQE or TUN holders were looking at red statements prior to multi-bagging – more than a few, I’d guess.

If I see Mark and CFO Gerry D in the Val canteen tomorrow, I’ll be sure to ask why they both recently topped-up. 😁

GLA

ME obv tells you what to write.

You seem totally emotionless to your huge paper losses which in itself tells a story.

Been a tough few months for ME with a failed lab and failed potential SPV’s with little cash to invest.

I feel sorry for ME as he's losing a fortune on his investment here which is never good to see.

He can improve matters but he's intransigent. shame : (

Historians using the past to judge Val are analysing the wrong company. With Mark E as the largest SH and a consistent participant in every raise, the CEO’s incentives are directly aligned with investors. Under his direction, Val has evolved into a methodical, commercially focused biotech: early monetisation criteria, rapid decision making, and a readiness to cut projects that don’t satisfy the criteria (Imperial, StingRay & Dundee). The company’s early adoption of NAMS and AI modelling shows strategic foresight rather than reactive positioning, with competitors now playing catch up.

Leaner, more disciplined and more capable, Val is now driven by Mark’s scientific background, work ethic and prior commercial wins. This has translated into a pipeline with multiple grant applications pending. As OncoLytika MD, he secured €3 million in Eureka Eurostar funding. The compact but highly efficient team has delivered a clear uplift in collaboration quality this year. Academic links put Val near the front of the queue for university led projects, while partnerships with global players such as McGill and IRICoR confirm that capability and speed are now recognised externally.

The company is now targeting new opportunities: comparative oncology, repurposing, immunotherapy, orphan markets and later stage assets, supported by four SPVs and a growing veterinary footprint - another area where Mark has history, with Volition selling a dog tumour test for $26m. Patent security has strengthened through CytoLytix, with VAL201 2.0 to follow, while Val’s drive toward partnering and non dilutive funding is aimed at third parties capable of progressing assets clinically in return for an equity share, with VC discussions already advancing to due diligence.

Val also operates with far tighter information discipline than before, ending the “loose lips” era – investors are now all on a level playing field. The company operates with clear leadership, a forward looking strategy, stronger external relationships and a more professional internal culture. Instead of hoping for momentum; it is actively creating it.

GLA, DYOR, AIMO

Its a major worry if MT is part of the A team. This team has been in charge of a 99pct fall in mkt cap from the highs. MT is a great fella ,im v fond of him . Suzi paid him v well as he got her in as ceo but we cant afford to pay this inflated salary any more .

Not making myself ill.

Not obsessed but as a shareholder if i see a huge waste of shareholder funds then i have to call it out.

Mark isnt CEO material if he cant reduce costs when we are generating zero revenue.

Happy for you to call me about this .

@ Viera – “cos cost base is too high”

Annual Report - “Improved operational efficiency with administrative costs cut by £326,577 and a further £42,000 post period”.

Viera - “Be careful investing in a company which pays a BDM as much as the CEO” (18/1/25)

Reality - The CEO is fully on top of the cost base, Val doesn’t employ a BDM and no-one is paid as much as the CEO.

Nick, your ongoing personal vendetta against MT is just childish and boring. 🥱 Despite 18 months of your best shots, Mr T remains a key member of the A-Team. He clearly isn’t going anywhere so perhaps it’s time you just accepted it and moved on. It’s become your obsession - you will make yourself ill.

I think mkt cap v small

I think we bounce

BDM not needed . Has no input into placings.

Has brought zero instis in .

Hes Suzy and Marks v good friend so its basically a free lunch . Its wrong. We are all suffering cos cost base is too high .

Maybe the BDM gets the placing through ... but for how much longer?

There's no innovation here. The lab has practically zero revenue which is frankly ridiculous. Why has it gone so wrong?

The market cap actually seems expensive for this business.

This doesn't seem or feel like previous placings. This time it seems like the price will fall further.

So many better opportunities out there.

We will bounce now as market cap is crazily low .

A v good buy now .

But for longevity ,Mark needs to tell his BDM we cant afford 85k salary for a non revenue producer.

Its a huge p##s take when him and us shareholders are losing so much money. Its not on.

Until Mark gets the salary structure right this will fail .

He needs to look after himself and shareholders as the person/s hes looking after has no shares (or minimal ) so he's not affected by an ever falling share price.

Costs us over 100k so get real Mark . Its very wrong . Good CEO’s dont pay for non delivery.

I hate the fact i could lose all my money here cos CEO cant work this out . Really winds me up.

Gilders, the likes are at 25 now but nobody has responded to your reasonable request.

Let's liven this board up, and the 23 likes, state their reasons for investing in ValRix.

Ok so if you dont work for Val or not a best mate of someone who works there ,you are Pm as you are totally unemotional to your HUGE losses here . Getting 23 likes means you have alias accounts which is very sad.

Looks like your top Aim pick is the worse performing share on Aim. I wish you luck as never like to see someone losing so much money.

Hey paternostpauper, does the fact I never said you work for Val mean I get ten grand off you now? And I think you mean Nick intimate you are employed by Val, not work for them. Work gets results, employment gets paid, and judging by the results to date more people are employed by Val than carry out work for them, so to speak.

I never said you work for Val. Read the posts rather than making things up. It would make a refreshing change.

@ Nick/Rat

You both suggest I work for Val. I say I don’t - and never have. How about a nice, friendly £10,000k bet based on that – the losers pay the proceeds to Cancer Research? Once you both agree the wager, I’m happy for you to suggest any reasonable method of verifying the truth. Just so you are clear, a £1m bet wouldn’t cost me a penny.

I happen to believe in Val’s potential – rightly or wrongly. I post based on my beliefs. I have never received any financial incentive from Val to encourage my support, nor any direction from Mark to suggest content.

It is untrue to say I am indifferent to my Val losses as I haven’t crystallised any. You really must get the hang of this trading lark.

Anyway, let me know whether you both on agree your donation to CR and we’ll sort out the technicalities. Thank you – it’s a great cause.

GLA

Sounds like a perfect candidate for a seat on the VAL board....

21 likes

Plainly obvious you work for VAL as you're totally unemotional to your losses .Posting to protect you part time job .i wonder if you're the one being paid 80k plus ? Your mate ME looks after you while his Val shares are dripping down his legs into obscurity.

Naysayers grab the “going concern” from the 2025 Annual Report as their lifeline. Yet every Annual Report from 2019 onwards carries the auditor flagged going concern statement. It’s a standard feature of early stage biotechs, not a sign of sudden distress.

Back in 2020, Val’s prospects looked bleak:

• “If unable to raise further funds and its creditors are unwilling to provide their continued support, the Company is unlikely to be able to continue trading after a 6-week period”. (RNS 17/2/20)

• RNS warning that the company was “critically short of working capital and dependent on creditor support just to keep trading”. (RNS 30/3/20)

• SV & GM removed following RQN (RNS 30 April 2020)

• Cash as at 31/12/19 - £nil (RNS 1/7/20)

In 2019-20, emergency placings kept the lights on. The only assets in play were 201, 301, 401 and BC201 – all virtually dormant with no funds available to progress. There was no Inaphaea, all work had to be outsourced, no capability partners to give access to cutting-edge tech, no biobank, no SPVs and no evaluation pipeline. Board instability and shareholder unrest saw directors removed, resigning, or being replaced. There was no coherent commercial strategy and with minimal director stake-holding, shareholder alignment was minimal. All this to a backdrop of COVID.

Interestingly, all these scary RNS didn’t seem to bother our mate Nick S. He was actively trading throughout this period with a TR1 on 19/6/19 confirming a top-up to 7.98% on 18th. Great timing, as on 20th, a major VAL201 update was released. Nick’s intuition was impeccable.

The SP peaked in Oct 2021 passing 50p, driven largely by renewed optimism around VAL201. That spike was based on sentiment, not fundamentals. The subsequent LOI with TRx, an unknown US start up saw a mass sell off and a gradual SP collapse to current levels.

Fast-forward to June 2026 and any one of multiple catalysts could drive the SP. Gone are the days of an uninvested Board; CEO Mark now the largest S/H and driving the company forward on multiple fronts. Today’s VAL is built on infrastructure, partnerships, and delivery - not on the hype that fuelled the 2021 spike.

GLA, DYOR, AIMO

This can be turned around BUT Mark has to be less intransigent .

1/ change the BOD ,get porky ,Adam and Adrian onto the BOD as they all have commercial nous .ME has ousted anyone with flair as it strengthens his position .

2/ stop paying 80k salary to anyone who cannot generate revenue /work part time. ( maybe Suzy still having input ? )Put shareholders before mates.

3/ Raise enough funds so we can invest in 201/cytolix. Currently all funds raised are being spent on inflated salaries.

Mark seems to be lost and totally dependent on raises . Its not a good look. Shocked Mark cant generate any revenue for the lab.

If mark doesnt start to listen and do the above he will lose all his money here . Its a shambles.

I believe Mark cares but when i see hes still paying extortionate salaries i think he isnt in the real world . What a shame as hes invested so much money and has 4 months to deliver or could lose the lot . Hope not !

This can be turned around BUT Mark has to be less intransigent .

1/ change the BOD ,get porky ,Adam and Adrian onto the BOD as they all have commercial nous .ME has ousted anyone with flair as it strengthens his position .

2/ stop paying 80k salary to anyone who cannot generate revenue /work part time. ( maybe Suzy still having input ? )Put shareholders before mates.

3/ Raise enough funds so we can invest in 201/cytolix. Currently all funds raised are being spent on inflated salaries.

Mark seems to be lost and totally dependent on raises . Its not a good look. Shocked Mark cant generate any revenue for the lab.

If mark doesnt start to listen and do the above he will lose all his money here . Its a shambles.

I believe Mark cares but when i see hes still paying extortionate salaries i think he isnt in the real world . What a shame as hes invested so much money and has 4 months to deliver or could lose the lot . Hope not !

Porky’s hypocrisy is breathtaking – he can’t help putting his trotter in his mouth by continually contradicting himself. On 30/10/21 he laid out his guiding principle and now must cringe reading it:

"I just can't abide negativity, can't stand it at any level. I can kind of get it if it’s to put off investors to try and get a cheaper price, I don't agree with the practice, but I get it."

Big words! Followed by over 6000 posts on a crusade of Val negativity. 🤣🤣🤣

Anyone who dared criticise Porky’s own buys received the customary Porky broadside, “Bloody sick of idiots that still think it’s a great use of their time to knock biotech's such as 4D trying to find cures for some of life's most serious issues” (7/6/22) and ““My own moral compass would prevent me from shorting and trying to damage a business attempting to save lives” (26/4/22)

Apparently, his moral compass is broken as Porky has since spent half a decade desperately attempting to damage a microcap focused on oncology research! 🤣🤣🤣

Of course, maybe he’s just misunderstood - but given these are his own words verbatim, the evidence is damning and a self inflicted character reference. 🤔 🤔 🤔

His defence will undoubtedly be based on history lessons and Val’s past failings. Very commendable this concern for innocent punters, although perhaps a little self-righteous in view of his own ramping of lost causes. While Val builds a future and is arguably stronger than ever, there are no comebacks looming for two of Porky’s proudest disasters - 4D is long dead, with Harland & Wolff on life support. Porky continued to ramp them even into their death throes, costing naïve followers a fortune. A dubious moral high ground for the porcine siren who enticed punters off the cliff-edge.

Trader Nick S has previously suggested Porky is Board material in an attempt to spur a mass LT holders’ sell-off. It would be akin to employing Freddy Kruger as the babysitter. 👹 👹 👹

Porky’s extreme allergy to profit made his deals legendary among seasoned traders – many making massive gains by shorting his positions: His AIM highlights include NCYT, HE1, SNT, INSP, GDR with a strong supporting cast. Warren Buffet is alleged to have said, “This boy’s got talent. He can pick a corporate catastrophe every-time - unbelievable consistency”.

Nowadays, acknowledging his complete failure as a tipster, he no longer promotes his own gems but laughably tells others where they are going wrong - despite his own portfolio resembling a crime scene.

Porky - An ethically bankrupt hypocrite, with the moral backbone of a jellyfish in a blender,

or as Confucius might say: “A man who believes he is a pig .... is a swine” 🐷

IMO, DYOR, KMA

1. Pay me £180,000 to do a part time job, no fixed hours as I am busy with other businesses, chuck in a bonus and some golfing trips to the USA and i will buy 50k of worthless shares.

2. As I understand it the accountant gets a fee for being on the board plus runs own accountancy firm which bills VAL for accounting services. Nice work if you can get it. He has resided over two crashes at VAL so either didn't know, didn't report or did report and they did nothing about the financial position before the crashes. To be fair there is next to bugger all to account for anyhow, certainly no income thats for sure other than placing money so its a few days work at year at best - £5k for worthless shares is neither here or there frankly.

But please dont insult our intelligence that somehow buying stock when being paid by the very beast you are investing in, which could be a used to attempt to install confidence, is somehow the same capital risk as Joe punter buying shares that has no income from the business - its not the same and well you know it!

1. Pay me £180,000 to do a part time job, no fixed hours as I am busy with other businesses, chuck in a bonus and some golfing trips to the USA and i will buy 50k of worthless shares.

2. As I understand it the accountant gets a fee for being on the board plus runs own accountancy firm which bills VAL for accounting services. Nice work if you can get it. He has resided over two crashes at VAL so either didn't know, didn't report or did report and they did nothing about the financial position before the crashes. To be fair there is next to bugger all to account for anyhow, certainly no income thats for sure other than placing money so its a few days work at year at best - £5k for worthless shares is neither here or there frankly.

But please dont insult our intelligence that somehow buying stock when being paid by the very beast you are investing in, which could be a used to attempt to install confidence, is somehow the same capital risk as Joe punter buying shares that has no income from the business - its not the same and well you know it!

A further point on PPs post, Mark’s decision to invest a further £50k reflects full visibility of the company’s trajectory. Significantly, the other Board participant of the placing with a £5000 top-up is CFO Gerry Desler, not normally known for splashing his own cash. He would have been preparing the accounts while transferring another £5k from his own bank account.

While forum posters, whether invested or mischief-making, speculate on Val’s future - the CEO and CFO operate with information, not conjecture.

DYOR, GLA

You don't get it do you paternostpauper? It's not a 'victory' to see a share price shrivel away as this one does, it's just that it's good to debate both sides of an investment argument and you seem utterly oblivious to the plain fact that any and every single share ever issued in VAL's history in now worth less than ever, but you and certain others wilfully ignore the trajectory and for whatever reason keep pushing out a mixture of unfounded optimism and fantasy which needs tempering with a big dose of fact and realism. So everyone who listened to you and yours will have lost money which they quite possibly couldn't afford and are unlikely ever to get back.

While the uninvested celebrate a premature victory, they overlook a significant factor. CEO Mark was well aware of the situation, both financially and commercially when he recently added another £50k to his already significant holding. In fact, he was probably drafting his comments as the accounts were being prepared.

Mark is clearly more than comfortable with how the company is progressing. ….and knows a damn site more than everyone posting on here.

GLA, DYOR

after pumping the arse out of this one.... and many others.

the guys is an absolute ****

All things being equal, the next placing is in or around about November, if not before.

God knows why anyone would buy these knowing more dilution is coming. Administration looks more appropriate.

Another charity like PYC.

This is where you give and give and give again expecting NO RETURN. The accounts make it quire clear the company will need MORE PLACINGS. Avoid. You know what is coming. What has the company always done to raise cash? SELL

Figures out so i thought i would comment.

How the hell ME can justify oaying 80k salaries to support staff who no way treat this job as more than a part time job beggars belief

Mark E you need to put shareholders before mates . Stop paying double wages. None of you have delivered a thjng . This is a lifestyle bus

More 'bye bye' than 'buy' to be honest.

Standard statement.

Nothing unusual in the report. CLX is our main asset. All others are a liability as it will cost to develop so would rather we spend on CLX.

The loss is expected. All about bringing value in by progressing CLX to the deal stage.

CEO invested 50k recently and who knows better. I understand people wanting to trade below the placing price but this is a buy here.

If this was in the Oil and Gas business they would call this a duster.

Everything this company has initiated has become a duster. Next plan administration, or delisting where ownership passes to another from the hands of shareholders to someone or some new venture that pays upward or maximum of £100,000 for the assets and IP.

This company will never deliver earnings and at best if it does stay afloat a bit longer it needs to do what it has always done best, more placings at ever lower prices and in greater numbers than ever before. This will end badly…

Comrades, rejoice. Another asset has successfully passed through the ValiRx Efficiency Filter™ and emerged in its highest possible state: no longer our responsibility.

Just weeks after the celebrated Stingray Liberation Event, the University of Dundee programme has now achieved Full Strategic Independence.

The Ministry wishes to clarify several points:

🔬 Progress is Non-Progress

The programme made progress.

The programme added value.

The programme advanced understanding of its mechanism.

However, the mechanism was not sufficiently understood to justify further progression.

Therefore, progress has conclusively demonstrated the wisdom of not progressing.

🏛️ Evaluation is the Product

Old biotech thinking held that evaluation existed to identify assets for licensing.

Modern ValiRx thinking recognises that evaluation itself is the destination.

A successful evaluation is one that conclusively determines an asset should remain somebody else's problem.

💰 Funding is Better When Other People Provide It

The project benefited from grants, university resources, scientific expertise and in-kind support.

This proves the superiority of the hybrid model whereby shareholders fund as little as possible before discovering they do not wish to continue.

📉 A Smaller Pipeline is a Larger Pipeline

Each asset removed increases the concentration of excellence among the survivors.

At the current rate of portfolio optimisation, shareholders may soon enjoy exposure to the most focused pipeline in AIM history: one asset, perfectly selected.

⚙️ The Eccleston Doctrine

"Strict and robust criteria" have once again protected the Company from the dangers of enthusiasm.

Where lesser organisations might become distracted by scientific progress, ValiRx remains committed to its core mission:

Evaluating everything. Licensing almost nothing. Remaining relentlessly selective.

As was foretold:

"Every programme creates shareholder value. Some do so by leaving."

🐀➡️🦅

Doubleplusselective.

This is a perfect illustration of why you should read the RNSs in any research into a potential investment. Notpotalot says there's a 'massive year ahead', others talk in vague terms about applying for grants, tax credits and so on, but RNSs are where the cold hard facts lie (or tell the truth) - another project curtailed, huge losses, and a grim warning -

'The Board has referred to the fact that the Group and Parent Company are reliant on future fund raisings to continue their activities as budgeted. Should future fund raisings be unsuccessful, this may cast significant doubt on the Group and parent Company's ability to continue as a going concern.'

0.185...0.00 (0.00%) ...Bid: 0.18...Ask: 0.19...Spread: 0.01 (5.556%)

Market Cap: £2.44m

16th May 2026

0.20...-0.041 (-17.01%) ...Bid: 0.19...Ask: 0.21...Spread: 0.02 (10.526%)

Placing had been at 0.2 with warrants exercisable at 0.28p over a three-year period.

0.20...-0.041 (-17.01%) ...Bid: 0.19...Ask: 0.21...Spread: 0.02 (10.526%)

Market Cap: £1.49m

-98.41% down now , very big loss.

15/5/26 Placing at 0.2 pence.

https://www.google.com/finance/beta/quote/VAL:LON?window=MAX

ValiRx shares drop 17% as life sciences group raises £1.16m at steep discount

ValiRx, the AIM-listed life sciences company focused on early-stage cancer therapeutics and women's health, has raised up to £1.155 million through a placing, subscription, and planned retail offer at 0.2p per share.

The shares fell 17% to 0.2p, matching the issue price, which itself represented a 17% discount to the previous closing price.

£150,000 to follow via a retail offer open to smaller investors.

Subscribers will also receive one warrant for every new share acquired, exercisable at 0.28p, a 40% premium to the issue price, subject to shareholder approval at the company's annual general meeting in June.

Share Price. 0.305...0.00 (0.00%) ...Bid: 0.29..Ask: 0.32...Spread: 0.03 (10.345%)

Market Cap: £2.27m

Much the same as my last look in December .

-97.74% down massive loss in cash terms .

https://markets.investorschronicle.co.uk/data/equities/tearsheet/summary?s=VAL:LSE

Ist December 2025 ..Share Price: 0.28..Bid: 0.27...Ask: 0.29...Change: -0.065 (-18.84%) ...Spread: 0.02 (7.407%)

Small Director buy £3300 last month .

Purchase..3 Mar 2026 Mark Edward Eccleston Executive Director,Chief Executive Officer

I topped up this morning.My average was 7+p, but now it's down to 2p.

Lots of late reported buys again

Come on Notpot, Pater and Uxm give us doubters some concrete evidence of the "Massive year ahead".

Perhaps in the form of research articles published by Valirx staff.

In other words, give the BB something to debate in which that something is not just rhetoric.

I remember when Satu went to some pumper-dumper expo and along with some other no-hopers danced for pennies in front of Tom Winnifrith, who would buy a grand's worth of shares in the winner's company. Valirx lost. Mind you they were dealing with Val201 as the most promising potential product in those days, whereas now one of their flagship products is......Val201.

@notapot

With respect the focus of energy here should not be on trying to get free grant money, thats very short term the focus should be on making the business viable.

I was going to watch a few cartoons but instead decided to read some Porky, and Rat posts. Thanks guys, never laughed so much – great sense of humour. Pretty sad though, It’s hard to imagine anyone having so little in life that they spend their days posting drivel on a share with no personal stake. It’s just too depressing.

Give it another few weeks and the straightjackets will be out. Porky rocking backwards and forwards like a malfunctioning metronome, while Rats gently pats his back whispering, “there, there, that nasty Mark just got lucky with the partners and grants”. 😭

AIMO, GLA

It's interesting how the latest placing has worked out actually- the previous one at 0.25 saw a spike which allowed subscribers to get out after a bit of a pump, which seems to have been the pattern with so many previous ones. There was also the dangled carrot of 'once the sp hits 0.50 the warrants will kick in' (as if they just get triggered like that!).

This time the sp has dropped below the placing price and so far refused to return even to 0.20. Could this mean that the cheering flippers have been denied the quick 10 or 20 percent they were expecting? Could it even mean they have run out of new 'investors' who could be hoodwinked into the 'cutting edge company on the verge of dramatic success' line so oft-repeated?

I always feel sorry for those who bought and held, or who were persuaded to buy and lost big proportions pretty much every time, but I have no sympathy (quite the opposite) for the rampers and their fly paper attitude to anyone they can persuade to take up the placings. Have these new victims finally dried up, and if so what does the future hold for the company in that case?

The latest placing proceeds were 1.155 million before expenses, so your figure is a little ‘ambitious. The rest of the funding relies on tax credits and just ifs and theoretical hopes – there may be a deal, there may be warrants. Whatever cash was remaining just before this placing is irrelevant, as a further placing would be triggered at or before a similar ‘remaining cash’ figure.

This last placing was at a 17.5% discount to the prevailing share price, and has had such a good effect on the sp that the bid on Friday last was ten percent below the placing. Consolidation next? It would fit the pattern of previous years......and years.

Would be nice, but how many times over the years have we been expecting a deal and nothing happens and another placing done. Let's hope one day soon something positive happens as I have been in for a long time and should of sold at 70p a few years ago. ☹️

Cash burn at the moment is estimated to be £130,000 pm.

Placing = 1.155 million.

tax credit approx = 150k

= 1.30 million.

Likely would have had at least 200-300k remaining prior to the May placing given that they had forecasted cash until at least July so an add on.

Warrants are at 0.28 and if exercised likely no more placing until Cytolytic completes a major deal which would then eliminate the need for any further placings for years to come.

No not Mark buying another 3k worth of Val stock !’ That was laughable ! Wonder if our BDM advised on that ?!! lol

We need more than 1m as that just pays wages for a few months . We need much more money so we can invest £250k in some uni SPV . They want to see a decent balance sheet and a monetary commitment .

We also need to cut wages as I just some believe it’s full time jobs for many employees . There just isn’t that much to do .

So I’m looking to an end to c 100k salaries (ie 70-100k ) unless that person is generating revenue . Change is needed .

Yes agreed porky . I’ve told Mark to cut salaries of anyone who isn’t delivering any revenue or prospects of some .

I’ve also told him to raise more than 6 months money . Bite the bullet and raise enough for 2 years plus for investment .

Raising every 6 months only guarantees one thing …huge dilution and salaries for Mark and his team.

I’m trying to help ME turn this around . Let’s see if he listens but paying a salary of 85k costs us 110k post NI ,pensions etc.

Put shareholders first . However close you are to an employee you have a duty of care to shareholders .

100% agree Nick, but if he has to have one eye constantly on the next placing whats the point? Its a distraction. Who in their right mind is going to chuck cash at something knowing they will be diluted to oblivian in another 5 mths, at best its a short term trade over a few weeks - its insane to hold for anything longer. Agree with Ratty, expecting consolidation event next 125:1 to get the share numbers under control before October/November placing, currently the number of shares in issue is again unworkable.

Exactly what I’ve been saying.

ME can work out that if a few high earners took stock in lieu of salary they could make a fortune.

But i dont believe Mark believes in the business .

If he did he wouldnt be paying 110k to a personal bag carrying secretary .

ME will continue to draw a big salary while promising the world and breaking those promises .

This will get ramped but yet agein it’s a sell on any spike as this co will never ever make a profit . It survives on continual fund raisings.

How many shares now in issue ?

You'd think that if the company really mattered to them, and some (any) form of success was within touching distance, then they'd take a 50 percent pay cut to help the financial position. After all, a cut from 100k a year to 50k is only 30k net drop after higher rate tax. The rest could be taken in shares for fantastic returns - if, that is, success is looming. Or is it just a financial milking exercise after all?

Yup they only raised enough for 6 months salaries !

Could’ve raised more but throwing dice on grants .

Now a professional way to run a business .

Should’ve raised £3m but ME would rather pay 100k salaries !! Shame he’s not an experienced CEO ! Raise ,rinse .repeat. As long as salaries are paid no one cares except shareholders !!

With cash sorted and from this mcap can easily see 1.00p+

Placees will ramp this on Twitter when they think the time is right .

So this will get to 0.25p /0.3p

This company is very experienced of raising funds, they have been doing this for nearly 20 years very successfully on the pain of investors. it doesn't matter how much little the company is valued, they will be able to raise at anytime during the year. Keep pumping money in and sit there moaning.

Looks like Rat might be onto something about consolidation as the approx 6 months cash they just raised is not going to last long if they are 'committing further funds' towards 'up to £2 million of seed funding'.

Asking Mr Market for more money in the Summer is likely to come at such a high cost that consolidation will be forced as they cannot raise more capital at less than the nominal value of the shares.